Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes

Author： Jennings Lisa K  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.1, Iss.4, 2005-12, pp. : 727-737

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Use of Intravenous Eptifibatide in Patients Undergoing Percutaneous Coronary Intervention: Acute Coronary Syndromes and Elective Stenting

By Juan F. Granada   Neal S. Kleiman  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 1, 2004-01 ,pp. : 31-41

Adis International

Access to resources Recommend Favorite

Eptifibatide: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Intervention and Acute Coronary Syndromes

By Plosker G.L.   Ibbotson T.  

PharmacoEconomics, Vol. 21, Iss. 12, 2003-01 ,pp. : 885-912

Adis International

Access to resources Recommend Favorite

Eptifibatide: A Review of its Use in Patients with Acute Coronary Syndromes and/or Undergoing Percutaneous Coronary Intervention

By Curran Monique P.   Keating Gillian M.  

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 2009-2035

Adis International

Access to resources Recommend Favorite

Eptifibatide: A Review of its Use in Patients with Acute Coronary Syndromes and/or Undergoing Percutaneous Coronary Intervention

By Goa K.L.   Noble S.  

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 439-462

Adis International

Access to resources Recommend Favorite

Antiplatelet therapy in acute coronary syndromes

By Menozzi Alberto   Lina Daniela   Conte Giulio   Mantovani Francesco   Ardissino Diego  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 27-42

Informa Healthcare

Access to resources Recommend Favorite